Annual Retained Earnings
-$311.36 M
-$62.68 M-25.21%
31 December 2023
Summary:
Lyra Therapeutics annual retained earnings is currently -$311.36 million, with the most recent change of -$62.68 million (-25.21%) on 31 December 2023. During the last 3 years, it has fallen by -$161.47 million (-107.73%). LYRA annual retained earnings is now -179.36% below its all-time high of -$111.45 million, reached on 31 December 2018.LYRA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$393.81 M
-$11.87 M-3.11%
30 September 2024
Summary:
Lyra Therapeutics quarterly retained earnings is currently -$393.81 million, with the most recent change of -$11.87 million (-3.11%) on 30 September 2024. Over the past year, it has dropped by -$97.61 million (-32.95%). LYRA quarterly retained earnings is now -208.25% below its all-time high of -$127.76 million, reached on 31 December 2019.LYRA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LYRA Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.2% | -33.0% |
| 3 y3 years | -107.7% | -119.0% |
| 5 y5 years | -179.4% | - |
LYRA Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -107.7% | at low | -119.0% | at low |
| 5 y | 5 years | -179.4% | at low | -208.3% | at low |
| alltime | all time | -179.4% | at low | -208.3% | at low |
Lyra Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$393.81 M(+3.1%) |
| June 2024 | - | -$381.94 M(+14.4%) |
| Mar 2024 | - | -$333.81 M(+7.2%) |
| Dec 2023 | -$311.36 M(+25.2%) | -$311.36 M(+5.1%) |
| Sept 2023 | - | -$296.20 M(+5.6%) |
| June 2023 | - | -$280.55 M(+5.9%) |
| Mar 2023 | - | -$264.93 M(+6.5%) |
| Dec 2022 | -$248.68 M | -$248.68 M(+6.1%) |
| Sept 2022 | - | -$234.44 M(+9.1%) |
| June 2022 | - | -$214.89 M(+7.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -$200.41 M(+3.6%) |
| Dec 2021 | -$193.40 M(+29.0%) | -$193.40 M(+7.6%) |
| Sept 2021 | - | -$179.78 M(+6.6%) |
| June 2021 | - | -$168.72 M(+7.0%) |
| Mar 2021 | - | -$157.69 M(+5.2%) |
| Dec 2020 | -$149.88 M(+17.3%) | -$149.88 M(+4.9%) |
| Sept 2020 | - | -$142.86 M(+4.6%) |
| June 2020 | - | -$136.53 M(+3.4%) |
| Mar 2020 | - | -$131.99 M(+3.3%) |
| Dec 2019 | -$127.76 M(+14.6%) | -$127.76 M |
| Dec 2018 | -$111.45 M | - |
FAQ
- What is Lyra Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Lyra Therapeutics?
- What is Lyra Therapeutics annual retained earnings year-on-year change?
- What is Lyra Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Lyra Therapeutics?
- What is Lyra Therapeutics quarterly retained earnings year-on-year change?
What is Lyra Therapeutics annual retained earnings?
The current annual retained earnings of LYRA is -$311.36 M
What is the all time high annual retained earnings for Lyra Therapeutics?
Lyra Therapeutics all-time high annual retained earnings is -$111.45 M
What is Lyra Therapeutics annual retained earnings year-on-year change?
Over the past year, LYRA annual retained earnings has changed by -$62.68 M (-25.21%)
What is Lyra Therapeutics quarterly retained earnings?
The current quarterly retained earnings of LYRA is -$393.81 M
What is the all time high quarterly retained earnings for Lyra Therapeutics?
Lyra Therapeutics all-time high quarterly retained earnings is -$127.76 M
What is Lyra Therapeutics quarterly retained earnings year-on-year change?
Over the past year, LYRA quarterly retained earnings has changed by -$97.61 M (-32.95%)